Kristine Ferrone

Dr. Kristine Ferrone

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Radiation
Verified
Journal Article
Open access
PDF file
KFKristine Ferrone
Kristine Ferrone
CWCharles Willis
Charles Willis
FGFada Guan
Fada Guan
JMJingfei Ma
Jingfei Ma
LPLeif Peterson
Leif Peterson
SKStephen Kry
Stephen Kry
The space radiation environment outside the protection of the Earth’s magnetosphere is severe and difficult to shield against. The cumulative effective dose to astronauts on a typical Mars mission would likely introduce risk exceeding permissible limits for carcinogenesis without innovative strategies for radiation shielding. Damaging cardiovascular and central nervous system effects are also expected in these space environments. There are many potential options for advanced shielding and risk mitigation, but magnetic shielding using superconductors offers several distinct advantages including using the conditions in space to help maintain the superconductor’s critical temperature and lower mass compared to equivalent passive shielding materials. Despite these advantages, the development of magnetic shielding technology has remained primarily in conceptual stages since the introduction of the idea in 1961. Over the last several decades, magnetic shielding has experienced periods of high and low attention by the human spaceflight community, leading to computational tools with single-use or other limitations and a non-uniform distribution of publications on the topic over time. Within the context of technology development and the surrounding space policy environment, this paper reviews and summarizes the available literature on the application of active magnetic shielding for space radiation protection, identifies challenges, and highlights areas for future research.

11 September 2012
Verified
Conference Paper
Closed access
JBJoseph Betser
Joseph Betser
KFKristine Ferrone
Kristine Ferrone
GRGregory Richardson
Gregory Richardson
JPJay Penn
Jay Penn
SMScott Martinelli
Scott Martinelli

17 March 2023 in Precision Radiation Oncology
Verified
Journal Article
Open access
KFKristine Ferrone
Kristine Ferrone
CWCharles E. Willis
Charles E. Willis
FGFada Guan
Fada Guan
JMJingfei Ma
Jingfei Ma
LPLeif E. Peterson
Leif E. Peterson
SKStephen F. Kry
Stephen F. Kry
Reliable estimates of radiation dose to bone marrow are critical to understanding the risk of radiation‐induced cancers. Although the medical internal radiation dose phantom is routinely used for dose estimation, bone marrow is not defined in the phantom. Consequently, methods of indirectly estimating bone marrow dose have been implemented based on dose to surrogate volumes or average dose to soft tissue. In this study, new bone marrow structures were implemented and evaluated to the medical internal radiation dose phantom in geant4, offering improved fidelity. The dose equivalent to the bone marrow was calculated across medical, occupational, and space radiation exposure scenarios, and compared with results using prior indirect estimation methods. Our results show that bone marrow dose may be overestimated by up to a factor of three when using the traditional methods when compared with the improved fidelity medical internal radiation dose method, specifically at clinical x‐ray energies.